Tech Company Financing Transactions

CaroGen Funding Round

CaroGen closed a $150 thousand Seed venture capital round on 9/10/2013. Backers included Connecticut Innovations.

Transaction Overview

Company Name
Announced On
9/10/2013
Transaction Type
Venture Equity
Amount
$150,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to grow operations in Hamden.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Farmington Ave.
Farmington, CT 06032
USA
Email Address
Not Recorded
Overview
CaroGen Corporation is an emerging biopharmaceutical company with an entirely new platform technology.
Profile
CaroGen LinkedIn Company Profile
Social Media
CaroGen Company Twitter Account
Company News
CaroGen News
Facebook
CaroGen on Facebook
YouTube
CaroGen on YouTube

Management Team

Title
Name
Email & Social
Chairman
John Rose
  John Rose LinkedIn Profile  John Rose Twitter Account  John Rose News  John Rose on Facebook
Chief Executive Officer
Bijan Almassian
  Bijan Almassian LinkedIn Profile  Bijan Almassian Twitter Account  Bijan Almassian News  Bijan Almassian on Facebook
VP - Product Management
Joseph Rininger
  Joseph Rininger LinkedIn Profile  Joseph Rininger Twitter Account  Joseph Rininger News  Joseph Rininger on Facebook
VP - R & D
Valerian Nakaar
  Valerian Nakaar LinkedIn Profile  Valerian Nakaar Twitter Account  Valerian Nakaar News  Valerian Nakaar on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/10/2013: Evident.io venture capital transaction
Next: 9/10/2013: Brandlive venture capital transaction

 

Share this article

 


News on VC Transactions

We document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary